Magnesium products’ claims fall short

TGA cancels 10 magnesium-containing medicines after reviews find insufficient evidence to back performance claims  Targeted compliance review conducted by the Therapeutic Goods Administration (TGA) of 21 medications containing magnesium found less than one-in-four had appropriate evidence to support exercise performance claims.   In an update published today (Thursday 7 May 2026) the regulator reported that insufficient evidence was provided for 16 of the